Market
The latest in market for medical-aesthetics practice owners.
Market
Allergan posts nine ASDS abstracts, two on GLP-1 patients
AbbVie's aesthetics arm will present nine abstracts at the ASDS meeting in San Diego, including two Phase 4 studies on patients taking GLP-1 weight-loss drugs.
Market
Revance survey: 74% say menopause raised aesthetic interest
A company-sponsored survey of 1,279 women links perimenopause to more demand for aesthetic care and for providers who understand hormonal aging.
Market
BOTOX Cosmetic Day returns Nov. 18 with Allē offers
Allergan Aesthetics sets its eighth BOTOX Cosmetic Day for Wednesday, Nov. 18, pairing a BOGO gift card offer with a November refer-a-friend credit.
Market
GLP-1 Pill Era Is Forcing Beauty Market Shift
Oral semaglutide adoption is reshaping filler and body-sculpting demand patterns.
Market
Semaglutide Pricing at Medspas: Compounded vs. Branded and What Patients Actually Pay
Medspa semaglutide costs range from $200–$600+ per month depending on dose, formulation source, and markup strategy—here's how the margin model works and what drives patient pricing.
Market
Semaglutide Face: Why Medspa Owners Should Offer Fillers to GLP-1 Patients
GLP-1 weight loss drives facial volume loss. Here's how to capture that filler revenue—and why patients are primed to buy.
Market
Offering GLP-1 Weight Loss at a Medspa: Sourcing, Compliance, and Revenue Model
How to evaluate GLP-1 as a revenue line, manage sourcing and prescriber requirements, and stay compliant with state and federal regulations.
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.